NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 212 filers reported holding NOVAVAX INC in Q2 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,028 | -2.6% | 142 | 0.0% | 0.00% | – |
| Q2 2023 | $1,055 | +7.2% | 142 | 0.0% | 0.00% | – |
| Q1 2023 | $984 | +98300.0% | 142 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -100.0% | 142 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $3,000 | -57.1% | 142 | 0.0% | 0.00% | -66.7% |
| Q2 2022 | $7,000 | -30.0% | 142 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $10,000 | -50.0% | 142 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $20,000 | -31.0% | 142 | 0.0% | 0.01% | -38.5% |
| Q3 2021 | $29,000 | -3.3% | 142 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $30,000 | +15.4% | 142 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $26,000 | +62.5% | 142 | 0.0% | 0.01% | +62.5% |
| Q4 2020 | $16,000 | +6.7% | 142 | 0.0% | 0.01% | -11.1% |
| Q3 2020 | $15,000 | +25.0% | 142 | 0.0% | 0.01% | +12.5% |
| Q2 2020 | $12,000 | +500.0% | 142 | 0.0% | 0.01% | +300.0% |
| Q1 2020 | $2,000 | – | 142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HELLMAN JORDAN MANAGEMENT CO INC /MA/ | 50,910 | $5,516,000 | 10.50% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 297,400 | $32,223,000 | 4.94% |
| Ikarian Capital, LLC | 375,400 | $40,675,000 | 2.94% |
| TSP Capital Management Group, LLC | 60,075 | $6,509,000 | 2.66% |
| RA Capital Management | 1,198,602 | $129,869,000 | 2.38% |
| Foresite Capital Management I, LLC | 66,810 | $7,239,000 | 2.04% |
| Healthcare Value Capital, LLC | 5,000 | $542,000 | 1.79% |
| Rock Springs Capital Management LP | 585,705 | $63,461,000 | 1.61% |
| Foresite Capital Management II, LLC | 67,373 | $7,300,000 | 1.59% |
| BERYLSON CAPITAL PARTNERS, LLC | 30,104 | $3,262,000 | 1.14% |